Figure 3 is titled “Standardized mean change in PTSD symptoms (measured by the Clinician-Administered PTSD Scale) for CPT compared with inactive comparators.” The figure displays a forest plot reporting the standardized mean difference in CAPS scores, CPT versus inactive comparators. This figure is described further in the “PTSD Symptoms” section as follows: “The meta-analysis that pooled CAPS scores (Figure 3) found a much greater decrease in PTSD symptoms for subjects treated with CPT than for those in inactive comparator groups (SMD, −1.35; 95% CI, −1.77 to −0.94, I2=71.1%, 5 studies, N=399). The meta-analysis had considerable statistical heterogeneity, but the direction of effects was consistent. The differences were only in the exact magnitude of benefit; all trials found moderate or large magnitudes of benefit.”

Figure 3Standardized mean change in PTSD symptoms (measured by the Clinician-Administered PTSD Scale) for CPT compared with inactive comparators

CAPS = Clinician-Administered PTSD Scale; CI = confidence interval; CPT = cognitive processing therapy; PTSD = posttraumatic stress disorder; SMD = standardized mean difference.

From: Results

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.